Here’s a rewritten version of the content:
Shark Tank India Features Kerala and Andhra Founders with Revolutionary Health Prediction Technology
Shark Tank India recently showcased three innovative founders from Kerala and Andhra Pradesh, who claimed to have developed a groundbreaking technology capable of predicting cancer and heart disease. Dr. Rajasekhara Reddy Ravuri, Dhaneesh Jameson, and Tony Jose are the brains behind Sugarstings.ai, a company that utilizes DNA-based medical predictions powered by machine learning. Their genetic test aims to identify diseases caused by gene mutations. During the pitch, the founders sought ₹1 crore in funding for a 2.5% equity stake, valuing their startup at ₹40 crore.
The founders emphasized that their product stands out in accuracy compared to similar offerings, which they claim only achieve 40% precision. While some of their bold assertions were toned down during the episode, their presentation left the Sharks intrigued. They explained that their test could detect genetic markers linked to cancer and heart conditions, potentially predicting these diseases before they manifest. Azhar Iqubal, co-founder of Inshorts, was visibly impressed by their claims.
However, the journey of Sugarstings.ai has been modest so far. Since its launch six months ago, the company has sold only 32 test kits. Out of these, four customers were flagged for potential cancer risks—though the founders acknowledged that these predictions could only be validated if the individuals were later diagnosed. The test is priced at ₹58,000, and the founders explained that customers perform the test at home after receiving it via courier. This process raised eyebrows, especially for Azhar, who felt that such a costly test should include professional assistance.
Aman Gupta, one of the Sharks, expressed skepticism about the test’s accuracy, particularly in a country where many people lack health insurance. "I’m not sure if this will be accurate or not," he said, questioning the reliability of the predictions. He also raised concerns about false positives, quipping, "Meri zindagi kharab ho jayegi (My life will be ruined)."
Vineeta Singh pointed out that while the test might be affordable for some, there was no concrete evidence to prove its effectiveness. Ritesh Agarwal echoed her concerns, highlighting that such technology is still in its infancy in India. Azhar stressed the importance of credible research backing any serious medical innovation, but the founders were unable to provide scientific evidence to support their claims.
Kunal Bahl saw potential in the concept but wasn’t convinced it was ready for the market. In the end, none of the Sharks made an offer, and the founders left without securing a deal.
This version maintains the original information while improving clarity and flow.
